The Food and Drug Administration issued a notice on Wednesday advising consumers not to inhale nitrous oxide products sold in ...

The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

The FDA has approved a novel inhalation powder for pulmonary arterial hypertension and interstitial lung disease-associated ...

Liquidia shares climbed 7.5% after disclosing that it is scheduled to make its first commercial shipment of Yutrepia inhalation powder, days after Food and Drug Administration approval. Shares were ...

Could Congress stamp out the national intoxicating hemp product market through a routine spending bill? With Congress balking ...

YUTREPIA now available to be prescribed to patients via specialty pharmaciesFDA approved YUTREPIA on May 23, 2025Court denies United Therapeutics’ request for preliminary injunction and a temporary ...

On Friday, the U.S. Food and Drug Administration (FDA) approved Liquidia Corporation's LQDA Yutrepia (treprostinil) ...

Report Ocean has published a new report on the Saudi Arabia Pharmaceutical Drug Delivery Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities.

Pursuant to that strategy, we remain on track to complete the technology transfer with our second-source drug substance contract ... trade name for molgramostim inhalation solution.

United Therapeutics Corp. (UTC) and Liquidia Technologies Inc. have been battling for close to a decade over their respective inhaled formulations ...

The Environmental Working Group published its Annual Guide to Sunscreens, finding that less than one in four SPF products are ...

received US Food and Drug Administration (FDA) approval for manufacturing and distributing generic Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)* Ritedose is the largest sterile ...